Jeantet advises Hoffmann Green Cement Technologies in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period, on an irreducible basis only, for its existing shareholders on Euronext Growth Paris

 

Paris, December 2, 2021 – Jeantet advised Hoffmann Green Cement Technologies in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, on an irreducible basis only, for its shareholders and of a global placement on Euronext Growth Paris, for a total amount of €22.5 million.

The total number of subscriptions collected related to 1,845,441 shares, i.e. €41.5 million on the basis of the subscription price of €22.50, representing a subscription rate of 185% of the total amount of the share capital increase. This share capital increase received the support from existing shareholders of Hoffmann Green Cement Technologies and from leading French and international institutional investors.

The subscription period to the transaction took place:

  • from November 23, 2021 to November 29, 2021 (inclusive) for the priority period of existing shareholders and the public offering (mainly intended for natural persons); and
  • from November 23, 2021 to November 30, 2021 (inclusive) for the global placement for institutional investors.

This transaction led to the approval by the French market authority of an EU recovery prospectus in accordance with article 14a and annex Va of the Prospectus Regulation as amended by regulation (EU) 2021/337 of February 16, 2021.

This share capital increase will provide Hoffmann Green Cement Technologies with additional resources to develop its international business, particularly through its licensing strategy, and to accelerate its development in France.

Hoffmann Green Cement Technologies designs, produces and distributes innovative clinker-

free low-carbon cement with a substantially lower carbon footprint than traditional cement. Fully aware of the environmental emergency and the need to reconcile the construction sector, cement manufacturing and the environment, the Group believes it is at the heart of a genuine technological breakthrough based on altering cement’s composition and the creation of a heat-free and clean manufacturing process, without clinker. Hoffmann Green’s cements, currently manufactured on a first 4.0 industrial site with no kiln nor chimney in western France, address all construction sector markets and present, at equivalent dosage and with no alteration in the concrete manufacturing process, higher performances than traditional cement.

The settlement-delivery of the new shares and their admission to trading on Euronext Growth Paris occurred on December 2, 2021.

Portzamparc (BNP Paribas Group) acted as global coordinator, lead manager and joint bookrunner, as well as Financial Advisor. ODDO BHF SCA acted as global coordinator, lead manager and joint bookrunner in connection with the transaction.

– –

Jeantet (deal counsel): Cyril Deniaud (Partner, Capital Markets), Benjamin Cohu (Associate, Capital Markets), Claire Coquard (Associate, Capital Markets), Jean-Guillaume Follorou (Partner, Tax) and François-Xavier Siméoni (Associate, Tax).

Our last press releases

JEANTET ADVISES THE AMERICAN FUND THOMA BRAVO IN ITS ACQUISITION OF TALEND

Paris, May 20th 2022 – Jeantet advised US investment fund Thoma Bravo in its financing of the acquisition of the Talend group, a leader in the field of integration and data integrity to the cloud valued at 2.4 billion US dollars. The transaction was financed by a bank debt arranged by the American fund Owl […]

Paris | BANK-FINANCE-REGULATORY

+

Jeantet advises Basler on the contemplated acquisition of i2s’ distribution business

Paris, 9 May 2022 – Jeantet has advised Basler AG, a company listed on the German stock exchange in Frankfurt am Main (Prime Standard), engaged in the design and manufacturing of high-quality, industrial cameras and embedded vision solutions, with respect to the contemplated acquisition of the distribution business of i2S SA, a company listed on […]

Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | TAX | EMPLOYMENT | IP, TECH & DATA

+

Jeantet advises Getinge on the contemplated acquisition of Fluoptics, a leader in fluorescence imaging as an aid to surgery

Paris, 3 May 2022 – Jeantet has advised the Swedish listed global medical technology company Getinge AB (publ), with respect to the contemplated acquisition via its French subsidiary Getinge Infection Control SAS of 100% of the shares and voting rights of Fluoptics SAS a leader in fluorescence imaging as an aid to surgery. The transaction […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA | FINANCING | REAL ESTATE

+

Jeantet advises FGI Worldwide on the financing of the ACAL BFI Group

Paris, 21 April 2022, Jeantet advised the US financing company FGI Worldwide LLC in support of the acquisition of the Acal BFI group by H2 Equity Partners. The credit facility was structured as an asset-based lending facility backed by a pool of assets in across multiple jurisdictions in Europe. ACAL BFi is a pan-European supplier […]

Paris | FINANCING | FINANCING

+

First edition of the Jeantet Student Excellence Award

Paris, April 13, 2022: Jeantet, in partnership with Queen Mary University of London’s Centre for Commercial Law Studies (CCLS) and the École de Droit de la Sorbonne , has organized the first edition of the Jeantet Student Excellence Award, in support of the Sorbonne – Queen Mary Double LLM programme and Queen Mary LLM students […]

Paris

+

Jeantet advises Figeac Aéro in connection with its financial restructuring

Paris, April 6, 2022 – Jeantet advises Figeac Aéro (listed on the regulated market of Euronext Paris, compartment B), a reference partner of major aeronautical corporations, in its financial restructuring. As part of this financial restructuring conducted under the aegis of the French Government’s Interministerial Committee on Industrial Restructuring (CIRI), an agreement was reached between […]

Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW | FINANCIAL, INDUSTRIAL AND SOCIAL RESTRUCTURING | BANKING AND FINANCE LAW

+

Jeantet advises Impact Expansion in connection with its acqusistion of a minority stake in SomniPlanet

Paris, 23 March 2022 – Jeantet advised Impact Expansion in connection with its acquisition of a minority stake in SomniPlanet. Based in Luxembourg and Paris, Impact Expansion is a private equity fund specializing in the environment, health and structural unemployment sectors. Founded in 2017 by Yann Goïot, Olivier Félix and Johann Sasco, SomniPlanet provides home […]

Paris | PRIVATE EQUITY | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises Housinganywhere in its acquisition of a majority stake in Studapart

Paris, February 17, 2022, Jeantet advised HousingAnywhere, the leading dutch accommodation marketplace on its acquisition of a majority stake in Studapart, the number one student rental accommodation platform in France. With this acquisition and after acquiring market leaders in Germany, Italy, Iceland and the Netherlands, HousingAnywhere consolidates its leading position in Europe by size and […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | BANK-FINANCE-REGULATORY | REAL ESTATE | IP, TECH & DATA

+

Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in Phodé

Paris, February 15, 2022 – Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in Phodé. This transaction allowed the exit of historical shareholders (including the investment fund Oraxys Environment 1) and the entry into the capital of the management team led by Damien Guillobez, who will become part of the […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises Medical Devices Venture on its listing on the euronext access + Paris market

Paris, on February 11, 2022, Jeantet advised Medical Devices Venture, a MedTech investment and acceleration platform, on its listing on the Euronext Access + Paris market, by way of direct admission following a €2.3 million private placement with industrial and financial investors in France and internationally. Medical Devices Venture, a subsidiary of Archos (itself listed […]

Paris | LISTED COMPANIES AND CAPITAL MARKETS LAW

+

Jeantet advised RHEA Group for the setting-up of a joint-venture, RHEA Cybersécurité France SAS

Paris, February 11, 2022 – Jeantet advised RHEA Group for the setting-up of a joint-venture, RHEA Cybersécurité France SAS, with Holding Amarante, the main shareholder of Amarante International. RHEA Cybersécurité France SAS gives both groups the opportunity to offer a unique physical and cybersecurity solution and a portfolio of services that can be tailored to […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | IP, TECH & DATA

+